Quiz: Role of Long Non-Coding RNAs in Ovarian Cancer

Article

How much do you know about the role of long non-coding RNAs in ovarian cancer? Now is your chance to find out.

In our September ovarian cancer quiz, you’ll be able to test your knowledge of the role long non-coding RNAs play in this disease. Here’s your first question:

1. In ovarian and other gynecologic cancers, long non-coding RNAs (lncRNAs) are key players in:

A. Cell proliferation

B. Invasion

C. Metastasis

D. All of the above


Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
Approximately 10% of patients discontinued treatment with avutometinib/defactinib due to toxicity in the phase 2 RAMP 201 trial.
Response rates appeared to be higher with avutometinib plus defactinib vs avutometinib alone in the phase 2 RAMP 201 study.